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Wernicke’s encephalopathy is an acute neurolopsychiatric syndrome caused by 
thiamine deficiency, and classically presents with the triad of opthalmopathy, atax-
ia and altered mentality. Both prolonged total parenteral nutrition and reduced oral 
intake can induce Wernicke’s encephalopathy during hematopoietic stem cell 
transplantation (HSCT). Although early treatment is important for recovery from 
Wernicke’s encephalopathy, the vague symptoms and characteristics hinder early 
diagnosis. Furthermore, Wernicke’s encephalopathy is not infrequent and can de-
velop at any age during HSCT. Herein, we present two young patients developing 
Wernicke’s encephalopathy during HSCT.
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INTRODUCTION
Wernicke’s encephalopathy is an acute neurolopsychiatric syndrome that was first 
described in 1881 by Carl Wernicke. Its symptoms include the classical triad of 
opthalmopathy, ataxia and an altered mental status.1 It has generally been associat-
ed with alcoholism and thiamine deficiency, but it is now found in a variety of 
clinical settings.1 We experienced two cases of Wernicke’s encephalopathy after 
prolonged period of total parenteral nutrition (TPN), after allogeneic bone marrow 
transplantation (BMT).
CASE REPORT
Case 1
A 10-year-old boy was admitted to the hospital for an allogeneic BMT. He was di-
agnosed with non-Hodgkin’s lymphoma 6 years previously, and the therapeutic 
procedure for the lymphoma was completed in October 2003. His disease relapsed 
in August 2007, and he was re-diagnosed with acute lymphoblastic leukemia 
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athy (Fig. 1B). The blood level of thiamine was low (0.2 U/
L; reference range 2-7 U/L). Thiamine was subsequently 
administered. Over the following two weeks, his mental 
status gradually, but not completely, improved. On D+50, 
he died of septic shock after suffering pneumonia, which 
developed after microaspiration.
Case 2
A 12-year-old boy underwent allogeneic BMT. He was di-
agnosed with Philadelphia chromosome positive acute lym-
phoblastic leukemia. After induction and consolidation che-
motherapy, the patient underwent the BMT. He received 
total body irradiation and cyclophosphamide administration 
for the conditioning procedure. Cyclosporine and metho-
trexate were used for the prevention of GVHD. He suffered 
from severe nausea and vomiting and could not orally take 
nutrition. On D+12, neutrophils were engrafted stably. Af-
ter the conditioning procedure was initiated, the patient was 
solely dependent on a commercially available parenteral 
nutrition product. His general activity was slightly poor. He 
responded slowly to requests, but his mental status was 
alert. On D+22, he seemed slightly drowsy and confused, 
and complained of marked dizziness. He could not walk to 
toilet and intermittently exhibited intention tremors on both 
hands. Lid nystagmus was observed, but there was no eye-
ball nystagmus. There were no sensory or motor changes. 
based on bone marrow aspiration and biopsy. Complete re-
mission was achieved, and an allogeneic BMT was planned. 
The patient underwent total body irradiation and cyclo-
phosphamide for the conditioning; tacrolimus and metho-
trexate were used for the prophylaxis of graft versus host 
disease (GVHD) and he was provided with an immunosup-
pressant. His oral intake was low, and he was solely depen-
dent on a commercially available total parenteral nutrition 
product. His neutrophils were engrafted on D+11. On D+11, 
he complained of dizziness and headache, but those symp-
toms quickly subsided. On D+23, vertigo and nystagmus 
developed, but his mental status was alert, and he did not 
show sensory or motor changes in the extremities. Three 
days later, he presented diplopia and esotropia, and com-
plained of difficulty in closing his eyes. Brain magnetic res-
onance imaging (MRI) was performed; we initially consid-
ered the toxicity of metronidazole or immunosuppressant 
(Fig. 1A). Metronidazole administration was discontinued. 
On D+30, he started to complain of dyspnea, and suffered 
simple and complex partial seizures one day later, which 
composed of lip smacking and clonic movements of the left 
shoulder. Apnea and bradycardia developed on D+33 and 
the patient was transferred to the intensive care unit for 
ventilator care. His mental status became semicomatose. 
The follow-up brain CT and clinical progress since metro-
nidazole discontinuation suggested Wernicke’s encephalop-
Fig. 1. (A) Symmetric signal increase on fast fluid-attenuated inversion-recovery images in the dorsal part of the medulla oblongata (black arrow, A1) same 
signal changes at the right side colliculus of the midbrain (arrow head, A2), the right precentral cortex (thin arrow, A3) and the bilateral putamen (white ar-
row, A4). (B) Non-contrast computed tomography scan taken 7 days later, shows low density lesions in the bilateral putamen (black arrow) and newly devel-
oped lesions in the bilateral caudate nucleus (arrow head). 
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symptoms are observed only in about 16% of patients.1 
Without thiamine treatment, the disease incurs 17-20% 
mortality and progresses to Korsakoff’s syndrome with 
memory impairment in 80% of cases.7 Progression to Kor-
sakoff’s syndrome is reduced among non-alcoholic Wer-
nicke’s encephalopathy patients compared to alcoholic 
ones. When Wernicke’s encephalopathy is due to thiamine 
deficiency alone, Korsakoff’s psychosis rarely develops 
following thiamine replacement. However, successful treat-
ment or prophylaxis of Wernicke’s encephalopathy depends 
on a number of related issues and is not simply a matter of 
supplementing thiamine.2 While thiamine replacement is 
important for the treatment and prophylaxis of Wernicke’s 
encephalopathy, an effective dosing template has not yet 
been established.8
Recently, Wernicke’s encephalopathy has been observed 
in a variety of cases not involving non-alcoholic patients, 
such as those undergoing gastrointestinal surgery, chronic di-
arrhea, hyperemesis gravidarum, anorexia nervosa, and can-
cer, etc.1 TPN without supplementation of thiamine some-
times causes Wernicke’s encephalopathy. The risk of thia-
mine deficiency increases when physicians fail to check the 
composition of commercially available TPN products.1,5,9,10 
Since a commercial form of TPN was first introduced to 
this hospital in 2004, there have been two severe cases of 
Wernicke’s encephalopathy following BMT.
Prior to this report, two cases of Wernicke’s encephalopa-
thy during hematopoietic stem cell transplantation (HSCT) 
have been reported in Korea, and both were adults.10,11 Both 
cases underwent HSCT and prolonged TPN, and fully re-
covered from Wernicke’s encephalopathy after thiamine in-
fusion. Our patients were much younger than those in the 
previous reports. Considering the fact that many cases of 
Wernicke’s encephalopathy are undiagnosed among alco-
MRI taken on D+24 revealed increased signal intensity on 
the dorsal pons on T1 weighted images (Fig. 2A). He was 
suspected of having Wernicke’s encephalopathy, and thia-
mine 100 mg was given for 7 days. Twenty-four hours after 
thiamine infusion began, his dizziness and mental status 
were remarkably improved, and all his symptoms cleared 
four days later (Fig. 2B).
DISCUSSION
Thiamine, in its biologically active form thiamine pyro-
phosphate, is an essential coenzyme used in the tricarboxil-
ic acid cycle and the pentose phosphate shunt for the me-
tabolism of carbohydrates and lipids. This is an important 
enzyme in energy metabolism involving transketolase, al-
pha ketoglutarate dehydrogenase, and pyruvate dehydroge-
nase. Without thiamine, the overwhelming metabolic de-
mand of brain cells leads to cellular energy deficit, focal 
acidosis, ultimate cell death,2 and lack of external balance. 
The requirement of thiamine is increased in critically ill pa-
tients or children and during lactation or pregnancy.1,3 Since 
the body’s store of thiamine is depleted after roughly 20 
days of poor supplementation, Wernicke’s encephalopathy 
can develop between days +13 to +37 after BMT as in our 
cases and other reports.4,5
Wernicke’s encephalopathy commonly develops in alco-
holics as a result of thiamine deficiency, although it remains 
largely underdiagnosed in this group. Typical brain lesions 
are observed in 0.8-2% of unselected autopsies of alcohol-
ics, but only 1-20% of these lesions are diagnosed clinical-
ly.6 Diagnosis of the disease is sometimes difficult because 
of non-specific initial symptoms such as headache, abdomi-
nal discomfort and fatigue; furthermore, the classic triad of 
Fig. 2. (A) Increased signal intensity on the bilateral medial lemnisci of the dorsal pons (arrow, T2 weighted image, A1) and the colliculi of the dorsal midbrain 
(arrow head, FLAIR, A2). (B) Improved lesions following 7 days of intravenous thiamine supplement (T2 weighted image and FLAIR, B1 and B2). FLAIR, fluid-
attenuated inversion-recovery.
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improved after thimanine replacement, but did not fully re-
cover. Furthermore, the patient experienced breathing diffi-
culties and ultimately cardiac arrest. In case 2, thiamine 
was provided immediately after its deficiency was suspect-
ed, and a full recovery was achieved.
In conclusion, Wernicke’s encephalopathy may develop at 
any age and not infrequently after HSCT. Wernicke’s en-
cephalopathy should be considered in patients with enceph-
alopathy following BMT or prolonged total parenteral nutri-
tion without adequate oral intake. Early treatment improves 
the prognosis of Wernicke’s encephalopathy cases. A multi-
vitamin and thiamine should be provided for patients who 
depend solely on TPN to prevent Wernicke-Korsakoff syn-
drome.
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